MarketScreener Strategies Pacira BioSciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-18 pm EDT			5-day change	1st Jan Change
24.15 ^USD	-0.98%		-0.78%	+28.18%

Jun. 11	Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee	CI
Jun. 05	Pacira Biosciences Insider Sold Shares Worth $377,226, According to a Recent SEC Filing	MT

No results for this search